<DOC>
	<DOC>NCT00343070</DOC>
	<brief_summary>Oral administration of escitalopram during 8 weeks; PET scan with 18F-FDG at inclusion and after 8 weeks</brief_summary>
	<brief_title>Functional Neuroimaging in Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder, Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Major Depression, Depressive episode, following DSMIV criteria MADRSscore &gt; 25 Age: 1865 yrs Medicationfree or antidepressant washout 7 days (for fluoxetine: 6 weeks) Lorazepam 1mg or zolpidem 10mg are allowed Suicidality Bipolar disorder, following DSMIV criteria Psychotic symptoms Substance abuse Personality disorder, following DSMIV criteria Cognitive dysfunction due to trauma capitis or dementia Diabetes mellitus Women without contraceptive protection, with pregnancy or breast feeding Pharmacological treatment or ingestion of substance that can influence cerebral perfusion less than a month before inclusion IQ below 80 Conditions not compatible with SPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>